Reply to Gelman, Gaudart, Pericchi: More reasons to revise standards for statistical evidence
- PMID: 24940581
 - PMCID: PMC4024871
 - DOI: 10.1073/pnas.1400338111
 
Reply to Gelman, Gaudart, Pericchi: More reasons to revise standards for statistical evidence
Conflict of interest statement
The author declares no conflict of interest.
Comment on
- 
  
  Revised standards for statistical evidence.Proc Natl Acad Sci U S A. 2013 Nov 26;110(48):19313-7. doi: 10.1073/pnas.1313476110. Epub 2013 Nov 11. Proc Natl Acad Sci U S A. 2013. PMID: 24218581 Free PMC article.
 - 
  
  Reproducibility issues in science, is P value really the only answer?Proc Natl Acad Sci U S A. 2014 May 13;111(19):E1934. doi: 10.1073/pnas.1323051111. Epub 2014 Apr 23. Proc Natl Acad Sci U S A. 2014. PMID: 24760820 Free PMC article. No abstract available.
 - 
  
  Revised evidence for statistical standards.Proc Natl Acad Sci U S A. 2014 May 13;111(19):E1933. doi: 10.1073/pnas.1322995111. Epub 2014 Apr 23. Proc Natl Acad Sci U S A. 2014. PMID: 24760821 Free PMC article. No abstract available.
 - 
  
  Adaptive revised standards for statistical evidence.Proc Natl Acad Sci U S A. 2014 May 13;111(19):E1935. doi: 10.1073/pnas.1322191111. Epub 2014 Apr 23. Proc Natl Acad Sci U S A. 2014. PMID: 24760822 Free PMC article. No abstract available.
 
References
- 
    
- DiMasi JA, Feldman L, Seckler A, Wilson A. Trends in risks associated with new drug development: success rates for investigational drugs. Clin Pharmacol Ther. 2010;87(3):272–277. - PubMed
 
 - 
    
- Gan HK, You B, Pond GR, Chen EX. Assumptions of expected benefits in randomized phase III trials evaluating systemic treatments for cancer. J Natl Cancer Inst. 2012;104(8):590–598. - PubMed
 
 
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
